-
Mashup Score: 0Old brains, new tricks: Surprising plasticity in adult vision - 9 month(s) ago
In a remarkable feat of engineering and scientific ingenuity, researchers at the Champalimaud Foundation have devised a first-of-its-kind setup for delivering complex visual stimuli within the limiting confines of a rodent Magnetic Resonance Imaging (MRI) scanner. This enabled them to open new vistas in understanding adult plasticity in the brain’s visual pathways, with implications for the fields of adult brain rehabilitation and visual restoration therapies.
Source: www.eurekalert.orgCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Whither Presbyopia Eye Drops? - 9 month(s) ago
By Andrew Beers, Associate Editor T he presbyopia marketplace is growing, but physicians and patients ar en’ t satisfied with some of the latest advancements in presbyopic treatments. Allergan offers the first presbyopia-correcting eye drop in the market, Vuity, and yet prescriptions have been trailing off since its release. Why is Vuity struggling to satisfy patients, and how can the pharmaceutical market bounce back? John Hovanesian, MD, an ophthalmologist at Harvard Eye Associates in Laguna Hills,
Source: www.reviewofophthalmology.comCategories: Latest Headlines, OphthalmologyTweet-
Whither Presbyopia Eye Drops?💧 Vuity is struggling on the market, but it might not be the end of presbyopia-correcting eye drops. Here’s a look at the current market and pipeline. https://t.co/pvk0uPSnka #ophthalmology #ophthalmologist #vision #vuity #allergan #presbyopia https://t.co/DFCV8tz2mz
-
-
Mashup Score: 1August 2023 Wills Eye Resident Case Series - 9 month(s) ago
By Erik Massenzio, MD, Christian Ponder, MD, and Mark Moster, MD A 63-year-old Caucasian female is referred to the Wills Eye Emergency Room after six days of vision loss in her right eye. She complains of pain with right eye movements, and notes she had a headache two weeks ago which has since resolved. She denies diplopia, jaw claudication, weight loss, scalp tenderness, polymyalgia, systemic neurologic symptoms or snoring. The patient had no significant past ocular history or past medical history. Past
Source: www.reviewofophthalmology.comCategories: Latest Headlines, OphthalmologyTweet-
August 2023 Wills Eye Resident Case Series A 63-year-old Caucasian female is referred to the Wills Eye ER after six days of vision loss in her right eye. https://t.co/NOTsQfMa5J @Wills_Eye #willseye #willseyehospital #ophthalmology #ophthalmologist #vision https://t.co/zw8FkUv0Q7
-
-
Mashup Score: 0From the VISION Trial: Improved Patient Outcomes with Lutetium-PSMA-617 - Karim Fizazi - 9 month(s) ago
In a discussion between Alicia Morgans and Karim Fizazi, they explore the quality of life outcomes from the VISION trial, published in Lancet Oncology. This Phase III trial examines the effects of Lutetium-PSMA-617 (also known as Pluvicto) on heavily pretreated metastatic castration-resistant prostate cancer patients. The study demonstrates a significant 38% reduction in the risk of death….
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
From the #VISION trial: Improved patient outcomes with lutetium-PSMA-617. Karim Fizazi, MD, PhD @GustaveRoussy joins @CaPsurvivorship @DanaFarber in this discussion on the quality of life outcomes from the VISION trial, published in @TheLancetOncol > https://t.co/oyV97QM19P https://t.co/cadr2QUlty
-
-
Mashup Score: 1Essentials for Top 10 Eye Emergencies - 10 month(s) ago
From ischemic optic neuropathy to acute third nerve palsy — familiarize yourself with these eye emergencies.
Categories: Latest Headlines, OphthalmologyTweet-
#Residents! When it comes to an #eye #emergency, taking immediate action is essential. Familiarize yourself with these 10 presentations to preserve #vision — quickly! #YOInfo https://t.co/rGXKISEeVA
-
-
Mashup Score: 0From the VISION Trial: Improved Patient Outcomes with Lutetium-PSMA-617 - Karim Fizazi - 10 month(s) ago
In a discussion between Alicia Morgans and Karim Fizazi, they explore the quality of life outcomes from the VISION trial, published in Lancet Oncology. This Phase III trial examines the effects of Lutetium-PSMA-617 (also known as Pluvicto) on heavily pretreated metastatic castration-resistant prostate cancer patients. The study demonstrates a significant 38% reduction in the risk of death….
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
From the #VISION trial: Improved patient outcomes with lutetium-PSMA-617. Karim Fizazi, MD, PhD @GustaveRoussy joins @CaPsurvivorship @DanaFarber in this discussion on the quality of life outcomes from the VISION trial, published in @TheLancetOncol > https://t.co/oyV97QM19P https://t.co/5QBdVljTLu
-
-
Mashup Score: 3Essentials for Top 10 Eye Emergencies - 10 month(s) ago
From ischemic optic neuropathy to acute third nerve palsy — familiarize yourself with these eye emergencies.
Categories: Latest Headlines, OphthalmologyTweet-
Residents! When it comes to an #eye #emergency, taking immediate action is essential. Familiarize yourself with these 10 presentations to preserve #vision — quickly! #YOInfo https://t.co/aP8kRtGCsZ
-
-
Mashup Score: 2
SNMMI 2023, Dual PSMA/FDG PET/CT, 177Lu-PSMA-617 radioligand therapy, metastatic castration-resistant prostate cancer (mCRPC), 68Ga-PSMA-11, 18F-fluorodeoxyglucose (18F-FDG) PET-CT, PSMA-FDG disease, PSMA-radioligand therapy, VISION trial.
Source: www.urotoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Dual PSMA/FDG PET/CT for assessing eligibility and predicting response in #mCRPC pts undergoing 177Lu-PSMA-617 radioligand therapy: a post-#VISION analysis. Presentation by Anushna Babu @aiims_newdelhi. #SNMMI23 coverage by @zklaassen_md > https://t.co/DmoIIwO1Xv @SNM_MI https://t.co/405p6LYMTr
-
-
Mashup Score: 0Researchers Provide Update on The ARMOR Study - 10 month(s) ago
Staphylococcal infections demonstrated greater susceptibility to even some older medications in the newest ARMOR study. Despite encouraging positive trends for S. aureus, multidrug resistance—microbial insensitivity to at least three medication classes—is still common for many organisms.Treating ocular infections is hard enough as is when the drugs work as advertised, and so much the worse…
Source: www.reviewofophthalmology.comCategories: Latest Headlines, OphthalmologyTweet-
Factors Linked to Visual Impairment in Myopic Glaucoma Study authors linked decreased acuity to specific locations suffering damage as well as the status of blood flow in the optic nerve head. Find the story here (scroll down): https://t.co/XkgH8jjOtD #myopia #glaucoma #vision https://t.co/C0VaFwFzHr
-
-
Mashup Score: 0Sequencing of Radiopharmaceuticals in Metastatic Castration-Resistant Prostate Cancer - Pedro Barata - 11 month(s) ago
In this conversation, Pedro Barata and Alicia Morgans discuss the sequencing of radiopharmaceuticals in metastatic castration-resistant prostate cancer. Reviewing several trials in this treatment landscape, including data from ALSYMPCA, VISION, REASSURE, WARMTH, and more recently, the RALU study Pedro Barata presents several different treatment scenarios where we can fit radium-223, among all…
Source: UroTodayCategories: General Medicine News, Latest HeadlinesTweet-
Sequencing of radiopharmaceuticals in metastatic castration-resistant #ProstateCancer. @PBarataMD @caseccc joins @CaPsurvivorship @DanaFarber to review data from #ALSYMPCA, #VISION, #REASSURE, #WARMTH, and the #RALU Study. #WatchNow > https://t.co/1MWSBMUda4 https://t.co/muUsbIGH7l
-
Researchers @ChampalimaudF devised a first-of-its-kind setup for delivering complex visual stimuli within the limiting confines of a #rodent Magnetic Resonance Imaging (#MRI) scanner #neuroplasticity #animalresearch #vision https://t.co/Z9WyWn4jqx